Fochon Pharmaceuticals, Ltd.
USPTO PatentsView assignee record - 8 granted patents across 3 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).
The verdict
According to USPTO PatentsView, Fochon ranks #31,667 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 3 technology areas.
- #31,667
- of 49,997 US assignees by volume
- 20th percentile
- by Innovation Score (26.3/100)
- 19.1
- avg claims per patent
USPTO PatentsView assignee plate
Corpus R31667 · Foreign Corporation #31,667 · 8 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH
- GRANTS-MICRO 8 grants
- MID-PACK #31,667/49,997
- PHOTO-FINISH Flow Labs
- CPC-NARROW A61P · 3 areas
- INNOV-THIN 26.3/100
- CLAIMS-RICH 19.1 claims/avg
- TYPE-FRNCORP Foreign Corp
- SPAN-YRS 2020–2025 · 6y
- BOOK-RICH 9/10 fields
Nearest grant-volume peer: Flow Labs, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Fochon’s 26.3 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Fochon
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Fochon Pharmaceuticals · this assignee 26
Fochon Pharmaceuticals · this assignee
26 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Fochon's Innovation Score is 26.3/100 (20th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Fochon?
Each dot is one of Fochon’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Fochon’s own 19.1 claims/patent is ABOVE the 17.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Fochon's grants concentrate
Fochon Pharmaceuticals, Ltd. is a focused PatentsView assignee: 3 CPC subclasses with 100% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2021 (4 grants) versus a trough of 1 in 2022. By volume, Fochon sits between Flow Labs, Inc. and Fontaine Modification Company.
Fochon's three-year grant acceleration
Fochon Pharmaceuticals, Ltd. shows 1 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Fochon's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Flow Labs
Flow Labs, Inc.
8 patents
- Fluence Automation
Fluence Automation LLC
8 patents
- Flusso
Flusso Limited
8 patents
- Flying Whales
Flying Whales
8 patents
- Focused Technolog…
Focused Technology Solutions, Inc.
8 patents
- Fondazione Teleth…
Fondazione Telethon ETS
8 patents
- Fontaine Engineer…
Fontaine Engineering und Maschinen GmbH
8 patents
- Fontaine Modifica…
Fontaine Modification Company
8 patents
- Fochon Pharmaceut… ◀
Fochon Pharmaceuticals, Ltd.
8 patents
What this shows Fochon holds 8 patents at rank #31,685, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Fochon
By rank, the assignees closest to #31,685 in granted patent volume.
- Flow Labs, Inc. #31,681 · 8 patents
- Fluence Automation LLC #31,682 · 8 patents
- Flusso Limited #31,683 · 8 patents
- Flying Whales #31,684 · 8 patents
- Focused Technology Solutions, Inc. #31,686 · 8 patents
- Fondazione Telethon ETS #31,687 · 8 patents
- Fontaine Engineering und Maschinen GmbH #31,688 · 8 patents
- Fontaine Modification Company #31,689 · 8 patents
Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)
Other assignees with the most granted patents in Fochon's primary technology class.
- The Regents of the University of California 1,387 in class
- Novartis AG 1,071 in class
- Merck Sharp & Dohme LLC 889 in class
- Bristol-Myers Squibb Company 879 in class
- Genentech, Inc. 789 in class
- The Board of Regents of the University of Texas System 744 in class
- Hoffmann-La Roche Inc. 722 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 721 in class
Fochon's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
26 20th percentile higher than 20% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 2 | 25.0% |
| 2021 | 4 | 50.0% |
| 2022 | 1 | 12.5% |
| 2025partial year | 1 | 12.5% |
Which technologies does Fochon Pharmaceuticals, Ltd. patent most?
Top 3 of 3 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Fochon Pharmaceuticals, Ltd.'s patent record in context - here's where to go next.
- Fochon Pharmaceuticals, Ltd.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 100% of its portfolio - see every assignee active in that class. Explore A61P
- Ranked #31,667 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Fochon Pharmaceuticals, Ltd. against Flow Labs, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 26.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.